Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AssigneeAstute Medical, Inc.
InventorsJoseph Anderberg, Jeff Gray, Paul McPherson, Kevin Nakamura, James Patrick Kampf
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstute Medical, Inc.
InventorsJoseph Anderberg, Jeff Gray, Paul McPherson, Kevin Nakamura, James Patrick Kampf
Estimating the term…
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of C—C motif chemokine 23, Transmembrane glycoprotein NMB, Brain-derived neurotrophic factor, Cathepsin S, Transforming growth factor beta-2, Urokinase-type plasminogen activator, Angiopoietin-2, Matrilysin, Carcinoembryonic antigen-related cell adhesion molecule 1, Creatine kinase MB, Insulin, Immunoglobulin M, Immunoglobulin E, Macrophage migration inhibitory factor, Galectin-3, Transforming growth factor beta-3, Heparan sulfate, soluble Cadherin-3, Complement C5, Platelet factor 4, Platelet basic protein, and Stromelysin-2 as diagnostic and prognostic biomarkers in renal injuries.
A method for evaluating renal status in a subject, comprising:
(canceled)
(canceled)
(canceled)
(canceled)
13-25. (canceled)
28-36. (canceled)
38-45. (canceled)
47-54. (canceled)
64-74. (canceled)
82-89. (canceled)
99-108. (canceled)
Dependencies are inferred from the claim text.